Urologische Klinik und Poliklinik » Forschung » Publikationen 2019

Publikationen 2019

High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma.
Hum Pathol 2019; 83(): 212-223
Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P, Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Höfler H, Haferkamp A, Geppert CI, Stöhr C, Hartmann A, German Network Of Kidney Cancer

Improved prediction of nephron-sparing surgery versus radical nephrectomy by the optimized R.E.N.A.L. Score in patients undergoing surgery for renal masses.
Minerva Urol Nefrol 2019; 71(3): 249-257
Sterzik A, Solyanik O, Eichelberg C, Jost M, Graser A, Lausenmeyer EM, Otto W, Waidelich R, Stief CG, Burger M, May M, Brookman-May SD

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Eur Urol 2019;
Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Montes SF, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Tahbaz R, Volpe A, Bex A

Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis.
Eur Urol Focus 2019;
Kretschmer A, Grimm T, Buchner A, Jokisch F, Ziegelmüller B, Casuscelli J, Schulz G, Stief CG, Karl A

Adjuvant therapy in renal cell carcinoma: the perspective of urologists.
Int J Clin Oncol 2019;
Spek A, Szabados B, Casuscelli J, Stief C, Staehler M

[Active surveillance of prostate cancer : An update].
Urologe A 2019; 58(3): 329-340
Chaloupka M, Westhofen T, Kretschmer A, Grimm T, Stief C, Apfelbeck M

[Current controversies in the treatment of localized prostate cancer].
Urologe A 2019;
Bischoff R, Chaloupka M, Westhofen T, Grimm T, Schlenker B, Weinhold P, Tilki D, Stief CG, Kretschmer A

Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes.
World J Urol 2019;
Grimm T, Grimm J, Buchner A, Schulz G, Jokisch F, Stief CG, Karl A, Kretschmer A

Long-term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study.
Neurourol Urodyn 2019; 38(2): 779-792
Mueller ER, van Maanen R, Chapple C, Abrams P, Herschorn S, Robinson D, Stoelzel M, Yoon SJ, Al-Shukri S, Rechberger T, Gratzke C

Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.
Eur Urol Focus 2019; 5(4): 642-649
Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic A, Arcila ME, Tennenbaum DM, Ghanaat M, Kashan M, Stief CG, Carlo M, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, Hsieh JJ, Hakimi AA

Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?
Cancer Treat Rev 2019; 75(): 20-26
Tsaur I, Heidegger I, Kretschmer A, Borgmann H, Gandaglia G, Briganti A, de Visschere P, Mathieu R, Valerio M, van den Bergh R, Ost P, Mirvald C, Tilki D, Ploussard G, Surcel C, EAU-YAU Prostate Cancer Working Party

Urological Infections: "The Time for Change is Now".
Eur Urol Focus 2019; 5(1): 1
Magistro G

Photothermal therapy enhanced the effectiveness of imiquimod against refractory cutaneous warts through boosting immune responses.
J Biophotonics 2019; 12(2): e201800149
Shi L, Luo M, Zhang F, Zhang L, Wang B, Liu P, Zhang Y, Zhang H, Yang D, Zhang G, Zhou F, Stepp H, Sroka R, Chen WR, Wang X

The Urinary Tract Microbiome: The Answer to All Our Open Questions?
Eur Urol Focus 2019; 5(1): 36-38
Magistro G, Stief CG

Vaccine Development for Urinary Tract Infections: Where Do We Stand?
Eur Urol Focus 2019; 5(1): 39-41
Magistro G, Stief CG

Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study.
Prostate Cancer Prostatic Dis 2019; 22(1): 101-109
Govers TM, Hessels D, Vlaeminck-Guillem V, Schmitz-Dräger BJ, Stief CG, Martinez-Ballesteros C, Ferro M, Borque-Fernando A, Rubio-Briones J, Sedelaar JPM, van Criekinge W, Schalken JA

Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
World J Urol 2019; 37(2): 243-251
Ploussard G, Borgmann H, Briganti A, de Visschere P, Fütterer JJ, Gandaglia G, Heidegger I, Kretschmer A, Mathieu R, Ost P, Sooriakumaran P, Surcel C, Tilki D, Tsaur I, Valerio M, van den Bergh R, EAU-YAU Prostate Cancer Working Group

Validation of a High-End Virtual Reality Simulator for Training Transurethral Resection of Bladder Tumors.
J Surg Educ 2019; 76(2): 568-577
Schulz GB, Grimm T, Buchner A, Jokisch F, Casuscelli J, Kretschmer A, Mumm JN, Ziegelmüller B, Stief CG, Karl A

The increase of stage, grading, and metastases in patients undergoing radical prostatectomy during the last decade.
World J Urol 2019; 37(6): 1103-1109
Beck V, Schlenker B, Herlemann A, Apfelbeck M, Buchner A, Gratzke C, Stief CG, Tritschler S

Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.
Eur Urol 2019; 75(1): 176-183
Fossati N, Suardi N, Gandaglia G, Bravi CA, Soligo M, Karnes RJ, Shariat S, Battaglia A, Everaerts W, Joniau S, van Poppel H, Rajarubendra N, Gill IS, Larcher A, Mottrie A, Schmautz M, Heidenreich A, Kalz A, Osmonov D, Juenemann KP, Herlemann A, Gratzke C, Stief C, Montorsi F, Briganti A

Distress in patients with renal cell carcinoma: a curious gap in knowledge.
BJU Int 2019; 123(2): 208-209
Bergerot CD, Battle D, Staehler MD, Pal SK

Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis.
Clin Cancer Res 2019; 25(4): 1165-1173
George DJ, Martini JF, Staehler M, Motzer RJ, Magheli A, Donskov F, Escudier B, Li S, Casey M, Valota O, Laguerre B, Pantuck AJ, Pandha H, Patel A, Lechuga MJ, Ravaud A

Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database (RECUR).
Eur Urol 2019; 75(2): 261-264
Dabestani S, Beisland C, Stewart GD, Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakikhani P, Marconi L, Fernandéz-Pello S, Monagas S, Williams SP, Torbrand C, Powles T, Van Werkhoven E, Meijer R, Volpe A, Staehler M, Ljungberg B, Bex A

Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
World J Urol 2019; 37(7): 1353-1360
Sievert KD, Schonthaler M, Berges R, Toomey P, Drager D, Herlemann A, Miller F, Wetterauer U, Volkmer B, Gratzke C, Amend B

Comparison of PIRADS 3 lesions with histopathological findings after MRI-fusion targeted biopsy of the prostate in a real world-setting.
Clin Hemorheol Microcirc 2019; 71(2): 165-170
Schlenker B, Apfelbeck M, Chaloupka M, Stief CG, Clevert DA

Impact of 68Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis.
J Nucl Med 2019; 60(7): 963-970
Schmidt-Hegemann NS, Chukwuka E, Minglun L, Rogowski P, Schaefer C, Stief C, Buchner A, Zamboglou C, Fendler WP, Ganswindt U, Cyran C, Bartenstein P, Belka C, Ilhan H

Metastatic papillary renal cell carcinoma in the era of targeted therapy - a retrospective study from three European academic centres.
Acta Oncol 2019; 58(3): 306-312
Stenman M, Staehler M, Szabados B, Sandström P, Laurell A, Lindskog M, Harmenberg U

[Value of imaging in upper urinary tract tumors].
Urologe A 2019; 58(1): 5-13
Schulz GB, Gresser EK, Casuscelli J, Strittmatter F, Tritschler S, Karl A, Stief CG, Nörenberg D

[Follow-up of renal cell carcinoma in a nonmetastatic stage].
Urologe A 2019; 58(1): 65-76
Szabados B, Foller S, Schulz GB, Staehler M, Grimm MO, Stief CG, Casuscelli J

In vitro efficacy of phytotherapeutics suggested for prevention and therapy of urinary tract infections.
Infection 2019;
Marcon J, Schubert S, Stief CG, Magistro G

Optimized management of urolithiasis by coloured stent-stone contrast using dual-energy computed tomography (DECT).
BMC Urol 2019; 19(1): 29
Magistro G, Bregenhorn P, Krauß B, Nörenberg D, D'Anastasi M, Graser A, Weinhold P, Strittmatter F, Stief CG, Staehler M

[Benign prostatic enlargement: symptoms, diagnostics and therapy].
MMW Fortschr Med 2019; 161(8): 50-57
Tamalunas A, Magistro G, Grimm T, Jokisch JF, Westhofen T, Schott M, Stief CG, Weinhold P

A Return to the Days of Radical Nephrectomy as the "Gold Standard" for Localized Renal Cell Carcinoma? Not So Fast.
Eur Urol 2019; 75(4): 546-547
Derweesh IH, Staehler M, Uzzo RG

[Complicated urinary tract infection: not always uncomplicated].
MMW Fortschr Med 2019; 161(1): 44-47
Bischoff R, Marcon J, Stief CG, Magistro G

Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.).
Scand J Urol 2019; (): 1-7
Dabestani S, Beisland C, Stewart GD, Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakikhani P, Marconi L, Fernandéz-Pello S, Monagas S, Williams SP, Powles T, Van Werkhoven E, Meijer R, Volpe A, Staehler M, Ljungberg B, Bex A

Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.
Clin Genitourin Cancer 2019; 17(1): 1-6
Msaouel P, Hong AL, Mullen EA, Atkins MB, Walker CL, Lee CH, Carden MA, Genovese G, Linehan WM, Rao P, Merino MJ, Grodman H, Dome JS, Fernandez CV, Geller JI, Apolo AB, Daw NC, Hodges HC, Moxey-Mims M, Wei D, Bottaro DP, Staehler M, Karam JA, Rathmell WK, Tannir NM

Imaging in Suspected Renal-Cell Carcinoma: Systematic Review.
Clin Genitourin Cancer 2019; 17(2): e345-e355
Vogel C, Ziegelmüller B, Ljungberg B, Bensalah K, Bex A, Canfield S, Giles RH, Hora M, Kuczyk MA, Merseburger AS, Powles T, Albiges L, Stewart F, Volpe A, Graser A, Schlemmer M, Yuan C, Lam T, Staehler M

[Novel minimally invasive treatment options for male lower urinary tract symptom].
Urologe A 2019; 58(3): 254-262
Magistro G, Stief CG, Gratzke C

New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic intervention.
Prostate 2019; 79(7): 746-756
Yu Q, Gratzke C, Wang Y, Wang X, Li B, Strittmatter F, Herlemann A, Wang R, Tamalunas A, Waidelich R, Stief CG, Hennenberg M

Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
J Urol 2019; 201(6): 1097-1104
Correa RJM, Louie AV, Staehler M, Warner A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, Swaminath A, Onishi H, Teh BS, Lo SS, Muacevic A, Siva S

Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma.
Front Oncol 2019; 9(): 11
Bergerot CD, Battle D, Bergerot PG, Dizman N, Jonasch E, Hammers HJ, George DJ, Bex A, Ljungberg B, Pal SK, Staehler MD

[Management of ureteral injuries].
Urologe A 2019; 58(2): 197-206
Ledderose S, Beck V, Chaloupka M, Kretschmer A, Strittmatter F, Tritschler S

Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE).
Eur Urol 2019; 75(4): 692-693
Kretschmer A, Gleave ME

Effect of combined sublethal X-ray irradiation and cyclosporine A treatment in NOD scid gamma (NSG) mice.
Exp Anim 2019; 68(1): 1-11
Walcher L, Müller C, Hilger N, Kretschmer A, Stahl L, Wigge S, Rengelshausen J, Müller AM, Fricke S

[Influence of modern diagnostic methods on the treatment of nonmetastatic castration-resistant prostate cancer].
Urologe A 2019;
Kretschmer A, Tilki D

Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?
World J Urol 2019; 37(2): 277-287
Marra G, Ploussard G, Futterer J, Valerio M, EAU-YAU Prostate Cancer Working Party

Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives.
Int J Urol 2019; 26(5): 532-542
Berquist SW, Yim K, Ryan ST, Patel SH, Eldefrawy A, Cotta BH, Bradshaw AW, Meagher MF, Bindayi A, McKay RR, Autorino R, Staehler M, Derweesh IH

Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review.
Eur Urol Oncol 2019; 2(2): 141-149
Ouzaid I, Capitanio U, Staehler M, Wood CG, Leibovich BC, Ljungberg B, van Poppel H, Bensalah K, Young Academic Urologists Kidney Cancer Working Group of the European Association of Urology

[Management of localized prostate cancer].
Urologe A 2019; 58(5)
Hadaschik B, Stief CG

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Lancet 2019;
Rini BI, Powles T, Atkins MB, Escudier B, McDermott DF, Suarez C, Bracarda S, Stadler WM, Donskov F, Lee JL, Hawkins R, Ravaud A, Alekseev B, Staehler M, Uemura M, De Giorgi U, Mellado B, Porta C, Melichar B, Gurney H, Bedke J, Choueiri TK, Parnis F, Khaznadar T, Thobhani A, Li S, Piault-Louis E, Frantz G, Huseni M, Schiff C, Green MC, Motzer RJ, IMmotion151 Study Group

What is the most relevent factor during ALA-PDT? A multi-center, open clinical pain score research about actinic keratosis, acne and condylomatata acuminata.
Photodiagnosis Photodyn Ther 2019;
Zheng Z, Zhang LL, Shi L, Zhang YF, Bo W, Wu QQ, Fang F, Wang WQ, Sroka R, Wang XL

Non-invasive measurement of erythrocyte zinc protoporphyrin in children.
Pediatr Res 2019; 85(3): 349-354
Homann C, Hennig G, Maier F, Stepp H, Holdt LM, Vogeser M, Sroka R, Koletzko B

Application of different noninvasive diagnostic techniques used in HMME-PDT in the treatment of port wine stains.
Photodiagnosis Photodyn Ther 2019; 25(): 369-375
Wen L, Zhang Y, Zhang L, Liu X, Wang P, Shen S, Hu C, Guo L, Jiang W, Sroka R, Wang X

Methadone enhances the effectiveness of 5-aminolevulinic acid-based photodynamic therapy for squamous cell carcinoma and glioblastoma in vitro.
J Biophotonics 2019;
Shi L, Buchner A, Pohla H, Pongratz T, Rühm A, Zimmermann W, Gederaas OA, Zhang L, Wang X, Stepp H, Sroka R

Comparative evaluation of tissue damage induced by ultrasound and impact dual-mode endoscopic lithotripsy versus conventional single-mode ultrasound lithotripsy.
World J Urol 2019;
Khoder W, Strittmatter F, Alghamdi A, Seitz M, Stief C, Bader MJ

[Aftercare of non-muscle invasive bladder cancer].
Urologe A 2019;
Schulz GB, Schlenker B, Stief CG

Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density.
Eur Radiol 2019;
Marcon J, Graser A, Horst D, Casuscelli J, Spek A, Stief CG, Reiser MF, Rübenthaler J, Buchner A, Staehler M

Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.
Urol Oncol 2019;
Schulz GB, Grimm T, Sers C, Riemer P, Elmasry M, Kirchner T, Stief CG, Karl A, Horst D

Anesthesia for Open Radical Retropubic Prostatectomy: A Comparison between Combined Spinal Epidural Anesthesia and Combined General Epidural Anesthesia.
Prostate Cancer 2019;
Kofler O, Prueckner S, Weninger E, Tomasi R, Karl A, Niedermayer S, Jovanovic A, Müller HH, Stief C, Zwissler B, von Dossow V

Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome.
Urol Int 2019;
Jokisch JF, Grimm T, Buchner A, Kretschmer A, Weinhold P, Stief CG, Karl A, Schulz GB

A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate.
J Biol Chem 2019;
Yu Q, Gratzke C, Wang R, Li B, Kuppermann P, Herlemann A, Tamalunas A, Wang Y, Rutz B, Ciotkowska A, Wang X, Strittmatter F, Waidelich R, Stief CG, Hennenberg M

Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series.
Clin Genitourin Cancer 2019;
Casuscelli J, Becerra MF, Seier K, Manley BJ, Benfante N, Redzematovic A, Stief CG, Hsieh JJ, Tickoo SK, Reuter VE, Coleman JA, Russo P, Ostrovnaya I, Hakimi AA

Extended follow-up of the AdVance XP male sling in the treatment of male urinary stress incontinence after 48 months: Results of a prospective and multicenter study.
Neurourol Urodyn 2019;
Grabbert M, Mumm JN, Klehr B, Kretschmer A, Gebhartl P, Gozzi C, Homberg R, May F, Rehder P, Stief CG, Bauer RM

Robotic-assisted Excision of Giant Prostatic Utricular Cysts: Technique, Outcomes and Follow-up.
Surg Technol Int 2019; 35
Khoder WY, Gratzke C, Kretschmer A, Becker A, Stief C

Factors associated with the decline of psychological support in hospitalized patients with cancer.
Psychooncology 2019;
Pichler T, Dinkel A, Marten-Mittag B, Hermelink K, Telzerow E, Ackermann U, Belka C, Combs S, Gratzke C, Gschwend J, Harbeck N, Heinemann V, Herkommer K, Kiechle M, Mahner S, Pigorsch S, Rauch J, Stief C, Beckmann J, Heußner P, Herschbach P

External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database.
Int J Clin Oncol 2019;
Zastrow S, Krabbe LM, Wolff I, Capitanio U, Klatte T, Ecke T, Huck N, Borgmann H, Scavuzzo A, Cindolo L, Schips L, Surcel C, Mirvald C, Cabo AV, Musquera M, Hutterer G, Procházková K, Stief C, Wirth M, May M, Brookman-May S

Benefits and Complications during the Stay at an Early Rehabilitation Facility after Radical Cystectomy and Orthotopic Ileum Neobladder Reconstruction.
Urol Int 2019;
Schulz GB, Grimm T, Buchner A, Kretschmer A, Stief CG, Karl A, Jokisch F

[Follow-up surveillance of muscle-invasive urinary bladder cancer after curative treatment].
Urologe A 2019; 58(9): 1093-1106
Schulz GB, Stief CG, Schlenker B

Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.
Eur Urol Oncol 2019;
Fernandéz-Pello S, Hora M, Kuusk T, Tahbaz R, Dabestani S, Abu-Ghanem Y, Albiges L, Giles RH, Hofmann F, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Volpe A, Ljungberg B, Bex A, Bensalah K

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma.
Eur Urol 2019; 76(2): 151-156
Albiges L, Powles T, Staehler M, Bensalah K, Giles RH, Hora M, Kuczyk MA, Lam TB, Ljungberg B, Marconi L, Merseburger AS, Volpe A, Abu-Ghanem Y, Dabestani S, Fernandéz-Pello S, Hofmann F, Kuusk T, Tahbaz R, Bex A

Rare patients in routine care - Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry.
Int J Cancer 2019;
Staehler M, Goebell PJ, Müller L, Emde TO, Wetzel N, Kruggel L, Jänicke M, Marschner N, RCC-Registry Group (Tumour Registry of Advanced Renal Cell Carcinoma)

Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma.
Cureus 2019; 11(3)
Schlemmer M, Spek A, Rodler S, Schott M, Casuscelli J, Staehler M

The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Eur Urol Focus 2019;
Correa RJM, Louie AV, Zaorsky NG, Lehrer EJ, Ellis R, Ponsky L, Kaplan I, Mahadevan A, Chu W, Swaminath A, Hannan R, Onishi H, Teh BS, Muacevic A, Lo SS, Staehler M, Siva S

Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial.
Clin Genitourin Cancer 2019;
Bracarda S, Bamias A, Casper J, Negrier S, Sella A, Staehler M, Tarazi J, Felici A, Rosbrook B, Jardinaud-Lopez M, Escudier B

Evidence of gleason 6 prostate cancer in mpMRI-targeted biopsy does not contribute to risk assessment of low risk prostate cancer.
Clin Hemorheol Microcirc 2019;
Chaloupka M, Bischoff R, Pfitzinger P, Lellig E, Ledderose S, Buchner A, Schlenker B, Stief C, Clevert DA, Apfelbeck M

Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.
Clin Hemorheol Microcirc 2019;
Apfelbeck M, Chaloupka M, Schlenker B, Stief CG, Clevert DA

A matched-pair analysis of patients with medium-sized prostates (50 cc) treated for male LUTS with HoLEP or TURP.
Low Urin Tract Symptoms 2019;
Magistro G, Westhofen T, Stief CG, Weinhold P

Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio's Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Eur Urol Focus 2019;
Correa RJM, Louie AV, Zaorsky NG, Lehrer EJ, Ellis R, Ponsky L, Kaplan I, Mahadevan A, Chu W, Swaminath A, Hannan R, Onishi H, Teh BS, Muacevic A, Lo SS, Staehler M, Siva S

How do elevated levels of testosterone affect the function of the human fallopian tube and fertility?-New insights.
Mol Reprod Dev 2019;
Dulohery K, Trottmann M, Bour S, Liedl B, Alba-Alejandre I, Reese S, Hughes B, Stief CG, Kölle S

Prospective evaluation of 4-D contrast-enhanced-ultrasound (CEUS) imaging in bladder tumors1.
Clin Hemorheol Microcirc 2019;
Jokisch F, Buchner A, Schulz GB, Grimm T, Weinhold P, Pfitzinger PL, Chaloupka M, Stief CG, Schlenker B, Clevert DA

Benefits and Limitations of Transurethral Resection of the Prostate Training With a Novel Virtual Reality Simulator.
Simul Healthc 2019;
Schulz GB, Grimm T, Kretschmer A, Stief CG, Jokisch F, Karl A

Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma.
Int J Cancer 2019;
Gerke JS, Orth MF, Tolkach Y, Romero-Pérez L, Wehweck FS, Stein S, Musa J, Knott MML, Hölting TLB, Li J, Sannino G, Marchetto A, Ohmura S, Cidre-Aranaz F, Müller-Nurasyid M, Strauch K, Stief C, Kristiansen G, Kirchner T, Buchner A, Grünewald TGP

Partial Nephrectomy in pT3a Tumors Less Than 7 cm in Diameter Has a Superior Overall Survival Compared to Radical Nephrectomy.
Cureus 2019; 11(9)
Ziegelmueller BK, Spek A, Szabados B, Casuscelli J, Buchner A, Stief C, Staehler M

Fournier´s Gangrene Under Sodium-Glucose Cotransporter 2 Inhibitor Therapy as a Life-Threatening Adverse Event: A Case Report and Review of the Literature.
Cureus 2019; 11(9)
Rodler S, Weig T, Finkenzeller C, Stief C, Staehler M